Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 13c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q3 EPS of ($0.79), $0.13 better than the analyst estimate of ($0.92).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c